What is the clinical significance of a red blood cell count of 5.18 ×10¹²/L, hematocrit of 46.7 %, and red cell distribution width of 15.7 %?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Interpretation of Laboratory Values

Your RBC count of 5.18 ×10¹²/L and hematocrit of 46.7% are within normal limits, but your elevated RDW of 15.7% is clinically significant and warrants further investigation, as it independently predicts increased mortality risk and suggests underlying pathological processes affecting red blood cell production or survival.

Understanding Your Results

Normal Parameters

  • RBC (5.18 ×10¹²/L): This falls within the normal reference range for adults
  • Hematocrit (46.7%): This is normal and indicates adequate red blood cell volume

The Critical Finding: Elevated RDW

Your RDW of 15.7% exceeds the normal upper limit (typically <14.5-15%) and places you at a critical threshold. Research demonstrates that RDW >15.7% is associated with over a two-fold increase in mortality risk 1. This cutoff has been validated across multiple studies showing:

  • In critically ill patients, RDW >15.8% carries a 2.61-fold increased risk of 30-day mortality 2
  • The optimal cutoff of 15.75% demonstrates 71% sensitivity and 89% specificity for predicting adverse outcomes 3
  • Your value sits precisely at this high-risk threshold

What Elevated RDW Indicates

An elevated RDW reflects anisocytosis (variation in red blood cell sizes) and signals underlying metabolic derangements 4:

  • Inflammation and oxidative stress
  • Impaired erythropoiesis (red blood cell production)
  • Nutritional deficiencies (iron, folate, vitamin B12)
  • Chronic disease states
  • Abnormal red blood cell survival

The combination of normal RBC/hematocrit with elevated RDW suggests early pathological changes before overt anemia develops.

Required Workup

Immediate laboratory evaluation should include 5:

  1. Complete metabolic panel - assess kidney and liver function
  2. Iron studies - serum ferritin and transferrin saturation to evaluate iron stores
  3. Vitamin B12 and folate levels - rule out megaloblastic processes
  4. Reticulocyte count - assess bone marrow response
  5. Inflammatory markers (CRP, ESR) - identify chronic inflammation
  6. Peripheral blood smear - directly visualize red blood cell morphology and confirm anisocytosis 6

Critical Screening Considerations

  • Gastrointestinal bleeding assessment - particularly if iron deficiency is identified 5
  • Chronic kidney disease screening - check creatinine and BUN, as CKD patients develop anemia with elevated RDW 5
  • Cardiovascular risk assessment - RDW predicts cardiovascular mortality 4
  • Infection surveillance - elevated RDW associates with bloodstream infections (1.44-fold increased risk at your level) 2

Clinical Pitfalls to Avoid

  • Do not dismiss elevated RDW as insignificant simply because hemoglobin and hematocrit are normal - RDW elevation precedes overt anemia
  • Do not attribute elevated RDW solely to age - it reflects active pathology requiring investigation 4
  • Hemoglobin measurement is preferred over hematocrit for ongoing monitoring due to better reproducibility 5

Prognostic Implications

The moderate discriminative power (AUC = 0.67) of RDW for mortality 2 means this is a robust independent risk factor that should trigger comprehensive evaluation rather than reassurance based on normal RBC/hematocrit alone. The fact that RDW remains significant after adjusting for multiple confounders across diverse patient populations 2, 3, 1 underscores its biological importance as a marker of systemic derangement.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.